There were 2,128 press releases posted in the last 24 hours and 403,432 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Kinnov Therapeutics Announces Positive Phase 2 Outcome: Key Milestone with Lead Drug KT-110 for Alcohol Use Disorder

TO:
Dr. Bill Mason
The Sage Group
+44 7785 950134

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image